Juno Therapeutics
Venture capital · Seattle, Washington, United States
Portfolio collected from the firm’s website, last checked Jun 29, 2026.Raises and exits come from each company’s own SEC and company records.
2Deep-tech portfolio0 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Fate Therapeutics
5Co-investorsShare a portfolio company
Portfolio · 2 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Fate Therapeutics | Biotech | Public | Jul 6, 2020 | $235.8M |
| Obsidian Therapeutics | Biotech | Public | Dec 8, 2017 | $32.4M |
Peer ranks
Portfolio size#189
Portfolio exits#103
Raises, 12 months#88
Co-investors#198
Co-investors
- ARCH VentureVenture capital1 shared
- Atlas VentureVenture capital1 shared
- Foresite CapitalVenture capital1 shared
- RA CapitalVenture capital1 shared
- TCG CrossoverVenture capital1 shared
Sectors
- Biotech2
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.